Professor and Chair, Milo Gibaldi Chair
University of Washington
Nina Isoherranen received her B.S. and M.S. in Analytical Chemistry from the Faculty of Science, University of Helsinki, Finland and her Ph.D. in Pharmaceutical Sciences from the School of Medicine, Hebrew University of Jerusalem, Israel. She continued her training as a Postdoctoral research fellow in Pharmaceutics in the Department of Pharmaceutics, University of Washington (UW). In 2004 she joined the faculty of the Department of Pharmaceutics at UW as an Acting Assistant Professor. She was promoted to a full Professor with tenure in 2017 and she is currently Chair of the Department of Pharmaceutics, UW and Milo Gibaldi Endowed Chair of Pharmaceutics.
Dr Isoherranen’s main research interests relate to vitamin A disposition, pharmacokinetic modeling and drug-drug interactions. Her NIH funded research incudes studies of the role of CYP26 and ALDH1A enzymes in Vitamin A homeostasis, alterations in vitamin A metabolome in obesity and related comorbidities and characterization of how drug and vitamin metabolism change during pregnancy. She has also active research ongoing in the area of pharmacokinetic modeling and PBPK model development relating to predictions of complex drug-drug and disease-drug interactions, and in developing models for renal clearance changes in different physiological states. Her laboratory has been continuously funded by the NIH for the last 16 years in these areas. She has trained numerous graduate students, post docs, PharmD students and undergraduate students in her laboratory. Dr Isoherranen has published over 130 peer reviewed manuscripts and eight book chapters and she holds three US patents.
Dr Isoherranen has received multiple young investigator and early career awards including Drug Metabolism Division Early Career Achievement Award by ASPET in 2013 and the ISSX North American New Investigator award in honor of James R Gillette in 2014.
Disclosure information not submitted.
Monday, April 25, 2022
8:00 AM – 1:30 PM ET
.png)